WEREWOLF THERAPEUTICS, INC. Restricted Cash
WEREWOLF THERAPEUTICS, INC. (HOWL) had Restricted Cash of $21.20 million as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2023-08-10
- 2023-06-30: Restricted Cash $21.20M.
- 2023-03-31: Restricted Cash $21.20M.
- 2022-12-31: Restricted Cash $1.20M.
- 2022-09-30: Restricted Cash $1.20M.
| Period end | Restricted Cash |
|---|---|
| 2023-06-30 | $21.20M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $21.20M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.20M 10-Q · filed 2023-08-10 |
| 2022-09-30 | $1.20M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.30M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.30M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.30M 10-K · filed 2023-03-23 |
| 2021-09-30 | $1.30M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.30M 10-Q · filed 2021-08-12 |
| 2020-12-31 | $200.00K 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |